Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10946079 Glycotargeting therapeutics

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

École Polytechnique Fédérale de Lausanne

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jeffrey A. Hubbell0

David Scott Wilson0

Date of Patent

March 16, 2021

0

Patent Application Number

148592920

Date Filed

September 19, 2015

0

Patent Citations

US Patent 10046056 Glycotargeting therapeutics

Patent Citations Received

US Patent 11666638 Glycotargeting therapeutics

0

US Patent 11801305 Glycotargeting therapeutics

US Patent 11253579 Compositions and methods for inducing immune tolerance

US Patent 11654188 Glycotargeting therapeutics

0

US Patent 11246943 Antigen-specific tolerance and compositions for induction of same

0

Patent Primary Examiner

Thea D'Ambrosio

0

Patent abstract

Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10946079 Glycotargeting therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool